SCHEMBL4946509

SCHEMBL4946509

Cc1ccc(C)c(-c2ccc(C(=O)NC(=N)N)o2)c1

nearest known ligand 0.62

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.62
HPGD P15428 5/20 0.62
KMT2A Q03164 3/20 0.62
MEN1 O00255 2/20 0.62
S1PR4 O95977 7/20 0.62
SLC9A1 P19634 5/20 0.61
KDM4E B2RXH2 3/20 0.42
MAPT P10636 3/20 0.42
POLB P06746 2/20 0.42
GLA P06280 1/20 0.42
GAA P10253 1/20 0.42
LMNA P02545 2/20 0.41
MAPK1 P28482 2/20 0.41
C3AR1 Q16581 1/20 0.41
RECQL P46063 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1330592 0.87 SLC9A1 (0.62) ALDH1A1HPGDKMT2AMEN1S1PR4
SCHEMBL4946438 0.87 SLC9A1 (0.62) ALDH1A1HPGDKMT2AMEN1S1PR4
SCHEMBL4943637 0.80 SLC9A1 (0.58) ALDH1A1HPGDKMT2AMEN1S1PR4
SCHEMBL4942893 0.80 ALDH1A1 (0.55) ALDH1A1HPGDKMT2AMEN1S1PR4
SCHEMBL4937731 0.79 SLC9A1 (0.61) ALDH1A1HPGDKMT2AMEN1S1PR4
SCHEMBL4936806 0.79 SLC9A1 (0.61) ALDH1A1HPGDKMT2AMEN1S1PR4
SCHEMBL4946641 0.78 SLC9A1 (0.57) ALDH1A1HPGDKMT2AMEN1S1PR4
SCHEMBL4946556 0.77 MEN1 (0.72) ALDH1A1HPGDKMT2AMEN1S1PR4
SCHEMBL3719309 0.77 SLC9A1 (0.57) ALDH1A1HPGDKMT2AMEN1S1PR4
SCHEMBL4937803 0.76 ALDH1A1 (0.49) ALDH1A1HPGDKMT2AMEN1S1PR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7351843-B2 Furancarbonylguanidine derivatives, their preparation and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2008-04-01 US claimed
US-20070299131-A1 Furancarbonylguanidine Derivatives, Their Preparation and Pharmaceutical Compositions Containing Them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2007-12-27 US claimed
US-7351843-B2 Furancarbonylguanidine derivatives, their preparation and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2008-04-01 US disclosed
US-20070299131-A1 Furancarbonylguanidine Derivatives, Their Preparation and Pharmaceutical Compositions Containing Them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2007-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299131-A1 Furancarbonylguanidine Derivatives, Their Preparation and Pharmaceutical Compositions Containing Them SLC9A1, NHERF1, SLC5A1 ALDH1A1 297/4885HPGD 242/4885KMT2A 4059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.